A detailed history of Aspen Capital Management, LLC transactions in Eli Lilly & CO stock. As of the latest transaction made, Aspen Capital Management, LLC holds 320 shares of LLY stock, worth $262,867. This represents 0.08% of its overall portfolio holdings.

Number of Shares
320
Holding current value
$262,867
% of portfolio
0.08%

Shares

1 transactions
Quarter Operation Price Per share shares change shares Held SEC Form
Q1 2025

May 05, 2025

BUY
$725.72 - $929.72 $232,230 - $297,510
320 New
320 $264 Million

Others Institutions Holding LLY

About ELI LILLY & Co


  • Ticker LLY
  • Exchange NYSE
  • Sector Healthcare
  • Industry Drug Manufacturers—General
  • Shares Outstandng 950,174,976
  • Market Cap $781B
  • Description
  • Eli Lilly and Company discovers, develops, and markets human pharmaceuticals worldwide. It offers Basaglar, Humalog, Humalog Mix 75/25, Humalog U-100, Humalog U-200, Humalog Mix 50/50, insulin lispro, insulin lispro protamine, insulin lispro mix 75/25, Humulin, Humulin 70/30, Humulin N, Humulin R, and Humulin U-500 for diabetes; and Jardiance, T...
More about LLY
Track This Portfolio

Track Aspen Capital Management, LLC Portfolio

Follow Aspen Capital Management, LLC and customize your updates to receive the information that matters most to you.

Portfolio Update

Get notified when there are updates to the investment portfolio of Aspen Capital Management, LLC, based on Form 13F filings with the SEC.

News

Stay updated on Aspen Capital Management, LLC with notifications on news.